E. Sylvestre
Please Note
30 records found
1
Monitoring Legionella in Drinking Water
Should We Focus on L. pneumophila or All Species to Effectively Protect Public Health?
Legionella pneumophila is responsible for the majority of reported Legionnaires' disease cases worldwide. However, environmental monitoring of building plumbing systems often targets a broad range of Legionella species, raising the question of whether monitoring should focus exclusively on L. pneumophila or include all Legionella species. This review examines the policy and public health implications of both strategies by assessing case attribution data for Legionnaires' disease, the environmental prevalence of Legionella species, and the validity of using non-pneumophila counts as indicators for L. pneumophila. Although over 30 species can cause illness, L. pneumophila dominates culture-confirmed cases despite the frequent detection of L. non-pneumophila species in building plumbing and other known sources. Ecological differences between species, including growth temperatures and disinfection resistance, arguably limit the suitability of L. non-pneumophila species as reliable indicators for L. pneumophila. As a result, using all Legionella species counts to inform risk management may lead to excessive interventions without proportional public health benefits. We conclude that routine monitoring should prioritize L. pneumophila to ensure targeted, cost-effective, and health-relevant risk management. Broader monitoring may be warranted in high-risk settings or where local epidemiological data justify a more inclusive approach. These findings support risk-based regulatory frameworks that align monitoring targets with public health outcomes.
Monitoring Frequencies for On-Site Water Reuse
A Risk-Based Framework Applied to Greywater Reuse
Quantification of Legionella pneumophila in building potable water systems
A meta-analysis comparing qPCR and culture-based detection methods
Foresight 2035
A perspective on the next decade of research on the management of Legionella spp. in engineered aquatic environments
The disease burden from Legionella spp. infections has been increasing in many industrialized countries and, despite decades of scientific advances, ranks amongst the highest for waterborne diseases. We review here several key research areas from a multidisciplinary perspective and list critical research needs to address some of the challenges of Legionella spp. management in engineered environments. These include: (i) a consideration of Legionella species diversity and cooccurrence, beyond Legionella pneumophila only; (ii) an assessment of their environmental prevalence and clinical relevance, and how that may affect legislation, management, and intervention prioritization; (iii) a consideration of Legionella spp. sources, their definition and prioritization; (iv) the factors affecting Legionnaires' disease seasonality, how they link to sources, Legionella spp. proliferation and ecology, and how these may be affected by climate change; (v) the challenge of saving energy in buildings while controlling Legionella spp. with high water temperatures and chemical disinfection; and (vi) the ecological interactions of Legionella spp. with other microbes, and their potential as a biological control strategy. Ultimately, we call for increased interdisciplinary collaboration between multiple research domains, as well as transdisciplinary engagement and collaboration across government, industry, and science as the way toward controlling and reducing Legionella-derived infections.
Quantitative microbial risk assessment for drinking water intake threat prioritization
A comparison of vulnerability and threat assessment according to source water protection regulations of two Canadian provinces
PFAS drinking water treatment trade-offs
Comparing the health burden of GAC treatment to the health benefits of reduced PFAS exposure
The risk of infection by enteric pathogens in bathing waters is generally monitored by using fecal indicator bacteria (FIB). Mechanistic models are efficient tools to predict FIB concentrations in bathing waters, both in near-future forecasting and in long-term climate change projections. However, most existing mechanistic FIB models are limited by the availability of observations for validation and incorporation of all relevant physical, biological, and chemical (physico-biochemical) processes. Therefore, the quantitative influence of different physio-biochemical processes and impact factors is missing. To enhance the understanding of FIB fate in different aquatic systems, we developed a comprehensive yet generically applicable physico-biochemical model, focused on Escherichia coli (E. coli). It includes a die-off module and a sediment interaction module. Separate validation of the two sub-modules demonstrated the reliability of our modeling approach. The die-off module shows a higher R2 value (0.88) and lower RMSE value (1.1 day-1) than the existing models (0.48–0.79, and 1.8–7.2 day -1). This demonstrated an improvement by adding Ultraviolet-A and Ultraviolet-B (UVB) inactivation and UV spectrum extinction due to colored dissolved organic matter (CDOM) absorption. According to our sediment module validation, considering the impact of sediment composition on E. coli attachment can improve the allocation of E. coli between waters and sediments. Sensitivity analysis showed that 1) photo-inactivation is important in low CDOM waters, but not in high CDOM waters, where the UV penetration is limited; 2) the impact of sediment interaction can extend the duration of a peak event in high turbid waters. This work demonstrated the dominant impact factors in different aquatic systems for E. coli prediction. The new generic model enables better simulation of bathing water quality across different types of aquatic environments, which can be a useful tool to inform management at bathing sites. Future applications can choose processes selectively from the new FIB physico-biochemical model and couple it with appropriate hydrological/hydrodynamic models to address specific environmental conditions and research purposes.
The Role of Aspiration in Legionnaires’ Disease
A Quantitative Microbial Risk Assessment (QMRA)-Based Comparison with Inhalation Exposures
To Treat or Not to Treat
Comparing Health Impacts of PFAS Exposure to Health Impacts of PFAS Removal Technologies
We performed a life cycle assessment to quantify the health lost (in DALYs) due to an increased regeneration frequency of granular activated carbon (GAC), which is used at a local drinking water producer to meet recent PFAS guidelines. To quantify the health gained by lower PFAS exposure, we fir st used the existing physiologically based pharmacokinetic model by EFSA to relate ?EFSA4 concentrations in drinking water to those in blood serum. Serum concentrations were then used in exposure response relationships from literature to relate them to an increase in disease occurrence, which was subsequently related to DALYs.
For all endpoints considered, we found that the gain in human health by removing PFAS from drinking water was in the same range as the loss of human health from the increased GAC regeneration. While the high uncertainty in PFAS health effects limits our ability to make a reliable comparison, it is likely that other interventions that limit PFAS exposure have a higher net benefit than drinking water treatment. For example, phasing out all non-essential uses of PFAS will lead to a decreased exposure via multiple routes, including diet. Altogether, PFAS limits in drinking water may need to be determined on a case-by-case basis, that considers the current concentration levels in addition to the secondary impact of the required treatment technologies. This study mainly serves to start a dialogue about this complex issue, which is particularly important as increasingly many PFAS are added to drinking water guidelines, most of which are even more challenging to remove than those currently included. ...
We performed a life cycle assessment to quantify the health lost (in DALYs) due to an increased regeneration frequency of granular activated carbon (GAC), which is used at a local drinking water producer to meet recent PFAS guidelines. To quantify the health gained by lower PFAS exposure, we fir st used the existing physiologically based pharmacokinetic model by EFSA to relate ?EFSA4 concentrations in drinking water to those in blood serum. Serum concentrations were then used in exposure response relationships from literature to relate them to an increase in disease occurrence, which was subsequently related to DALYs.
For all endpoints considered, we found that the gain in human health by removing PFAS from drinking water was in the same range as the loss of human health from the increased GAC regeneration. While the high uncertainty in PFAS health effects limits our ability to make a reliable comparison, it is likely that other interventions that limit PFAS exposure have a higher net benefit than drinking water treatment. For example, phasing out all non-essential uses of PFAS will lead to a decreased exposure via multiple routes, including diet. Altogether, PFAS limits in drinking water may need to be determined on a case-by-case basis, that considers the current concentration levels in addition to the secondary impact of the required treatment technologies. This study mainly serves to start a dialogue about this complex issue, which is particularly important as increasingly many PFAS are added to drinking water guidelines, most of which are even more challenging to remove than those currently included.
Modelling exposure to aerosols from showers
Implications for microbial risk assessment
Greywater recycling for diverse collection scales and appliances
Enteric pathogen log-removal targets and treatment trains
In light of increasingly diverse greywater reuse applications, this study proposes risk-based log-removal targets (LRTs) to aid the selection of treatment trains for greywater recycling at different collection scales, including appliance-scale reuse of individual greywater streams. An epidemiology-based model was used to simulate the concentrations of prevalent and treatment-resistant reference pathogens (protozoa: Giardia and Cryptosporidium spp., bacteria: Salmonella and Campylobacter spp., viruses: rotavirus, norovirus, adenovirus, and Coxsackievirus B5) in the greywater streams for collection scales of 5-, 100-, and a 1000-people. Using quantitative microbial risk assessment (QMRA), we calculated LRTs to meet a health benchmark of 10–4 infections per person per year over 10′000 Monte Carlo iterations. LRTs were highest for norovirus at the 5-people scale and for adenovirus at the 100- and 1000-people scales. Example treatment trains were designed to meet the 95 % quantiles of LRTs. Treatment trains consisted of an aerated membrane bioreactor, chlorination, and, if required, UV disinfection. In most cases, rotavirus, norovirus, adenovirus and Cryptosporidium spp. determined the overall treatment train requirements. Norovirus was most often critical to dimension the chlorination (concentration × time values) and adenovirus determined the required UV dose. Smaller collection scales did not generally allow for simpler treatment trains due to the high LRTs associated with viruses, with the exception of recirculating washing machines and handwashing stations. Similarly, treating greywater sources individually resulted in lower LRTs, but the lower required LRTs nevertheless did not generally allow for simpler treatment trains. For instance, LRTs for a recirculating washing machine were around 3-log units lower compared to LRTs for indoor reuse of combined greywater (1000-people scale), but both scenarios necessitated treatment with a membrane bioreactor, chlorination and UV disinfection. However, simpler treatment trains may be feasible for small-scale and application-scale reuse if: (i) less conservative health benchmarks are used for household-based systems, considering the reduced relative importance of treated greywater in pathogen transmission in households, and (ii) higher log-removal values (LRVs) can be validated for unit processes, enabling simpler treatment trains for a larger number of appliance-scale reuse systems.
Monitoring ESBL- Escherichia coli in Swiss wastewater between November 2021 and November 2022
insights into population carriage
Hands Are Frequently Contaminated with Fecal Bacteria and Enteric Pathogens Globally
A Systematic Review and Meta-analysis